Dr. Jan Griffin and Dr. C. Michael Gibson discuss: Long-term benefits with acoramidis on Kansas City cardiomyopathy questionnaire-overall summary (KCCQ-OS) score and serum transthyretin levels in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)